(Q37401586)

English

The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea

scientific article published on February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea (English)

1 reference

Europe PubMed Central

20 August 2017

0 references

0 references

0 references

Clostridium difficile

object named as

Clostridium difficile

1 reference

based on heuristic

inferred from title

author name string

Cynthia L Rohde

1

1 reference

Europe PubMed Central

20 August 2017

Vickie Bartolini

2

1 reference

Europe PubMed Central

20 August 2017

Nicole Jones

3

1 reference

Europe PubMed Central

20 August 2017

publication date

1 February 2009

1 reference

Europe PubMed Central

20 August 2017

Nutrition in Clinical Practice

1 reference

Europe PubMed Central

20 August 2017

24

1 reference

Europe PubMed Central

20 August 2017

33-40

1 reference

Europe PubMed Central

20 August 2017

1

1 reference

Europe PubMed Central

20 August 2017

Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Probiotics and their fermented food products are beneficial for health

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Recommendations for surveillance of Clostridium difficile-associated disease.

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Past, present, and future therapies for Clostridium difficile-associated disease

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Clostridium difficile--Associated diarrhea: A review

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Probiotics and gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Covert assessment of concurrent and construct validity of a chart to characterize fecal output and diarrhea in patients receiving enteral nutrition.

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1177%2F0884533608329297

21 January 2018

Identifiers

10.1177/0884533608329297

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37401586&oldid=1734150917"